Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAK7 Class: Corporate Bond - Foreign US$

Pacer Advisors, Inc.'s Holding History (CIK: 0001616667)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 125,000 Value ($000) $130 Avg Close — Range —
Q3 2025
Shares 101,000 Value ($000) $105 Avg Close — Range —
Q2 2025
Shares 150,000 Value ($000) $156 Avg Close — Range —
Q1 2025
Shares 90,000 Value ($000) $92 Avg Close — Range —
Q4 2024
Shares 206,000 Value ($000) $211 Avg Close — Range —
Q2 2024
Shares 117,000 Value ($000) $120 Avg Close — Range —
Q1 2024
Shares 167,000 Value ($000) $171 Avg Close — Range —
Q4 2023
Shares 167,000 Value ($000) $171 Avg Close — Range —
Q3 2023
Shares 167,000 Value ($000) $164 Avg Close — Range —
Q2 2023
Shares 292,000 Value ($000) $288 Avg Close — Range —